Skip to content

Clinical trials

Dermatomyositis trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20171
20211
20222
20231
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting3
Active, not recruiting2
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Chugai Pharmaceutical2
argenx2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Bristol-Myers Squibb1
N.M. Wulffraat1
Novartis Pharmaceuticals1
Octapharma1
Priovant Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis12
Myositis6
Polymyositis5
Lupus Erythematosus, Systemic3
Antiphospholipid Syndrome2
Arthritis, Rheumatoid2
Behcet Syndrome2
Lung Diseases, Interstitial2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic, Idiopathic2

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.